Literature DB >> 9723226

Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the International Neoral TDM Advisory Consensus Meeting (Vancouver, November 1997).

P Keown1, B D Kahan, A Johnston, G Levy, S P Dunn, F Cittero, J M Grino, P F Hoyer, P Wolf, P F Halloran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9723226     DOI： 10.1016/s0041-1345(98)00375-3

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  13 in total

Review 1.  Therapeutic drug monitoring of immunosuppressant drugs.

Authors:  A Johnston; D W Holt
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

2.  Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients.

Authors:  Hélène Bourgoin; Gilles Paintaud; Matthias Büchler; Yvon Lebranchu; Elisabeth Autret-Leca; France Mentré; Chantal Le Guellec
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

3.  Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants.

Authors:  Frédéric Leger; Jean Debord; Yann Le Meur; Annick Rousseau; Mathias Büchler; Gérard Lachâtre; Gilles Paintaud; Pierre Marquet
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.

Authors:  María del Mar Fernández De Gatta; Dolores Santos-Buelga; Alfonso Domínguez-Gil; María José García
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Cyclosporine A monitoring--how to account for twice and three times daily dosing.

Authors:  Samuel Fanta; Janne T Backman; Paula Seikku; Christer Holmberg; Kalle Hoppu
Journal:  Pediatr Nephrol       Date:  2005-03-17       Impact factor: 3.714

Review 6.  Methods for clinical monitoring of cyclosporin in transplant patients.

Authors:  R J Dumont; M H Ensom
Journal:  Clin Pharmacokinet       Date:  2000-05       Impact factor: 6.447

Review 7.  Distribution of cyclosporin in organ transplant recipients.

Authors:  Fatemeh Akhlaghi; Andrew K Trull
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  Cyclosporin therapeutic drug monitoring--an established service revisited.

Authors:  Raymond G Morris
Journal:  Clin Biochem Rev       Date:  2003-05

9.  Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC(0-12) monitoring in cardiac transplant recipients over the first year post-transplantation.

Authors:  C Monchaud; A Rousseau; F Leger; O J David; J Debord; T Dantoine; P Marquet
Journal:  Eur J Clin Pharmacol       Date:  2003-03-06       Impact factor: 2.953

10.  Ciclosporin population pharmacokinetics and Bayesian estimation in thoracic transplant recipients.

Authors:  Dorothée Fruit; Annick Rousseau; Catherine Amrein; Florence Rollé; Nassim Kamar; Laurent Sebbag; Michel Redonnet; Eric Epailly; Pierre Marquet; Aurélie Prémaud
Journal:  Clin Pharmacokinet       Date:  2013-04       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.